Laurent S.
- Country
- France
- Department
- Médecine interne
Research Overview
- Phase 3 Study on the Efficacy and Safety of Cenerimod in Adults with Moderate-to-Severe Systemic Lupus Erythematosus
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Ianalumab in Systemic Lupus Erythematosus Patients on Standard-of-Care Therapy
- Long-term Safety and Tolerability Assessment of Ianalumab in Systemic Lupus Erythematosus: A Randomized, Double-blind, Placebo-controlled Extension Study
Data & Insights
Has run more than one trial at 99 of 224 partner sites.
Specializations
Autoimmune Vasculitis
Specializes in the treatment of Giant Cell Arteritis (GCA), conducting research into various therapeutic approaches including evaluation of treatment discontinuation strategies and comparative therapy effectiveness.
- Corticosteroid-sparing treatments
- Novel biological therapies
- Treatment optimization protocols
Explores innovative therapeutic options for Eosinophilic Granulomatosis with Polyangiitis (EGPA).
Systemic Lupus Erythematosus
Investigates advanced treatments for Systemic Lupus Erythematosus (SLE) and its complications, with particular focus on novel therapeutic agents and their long-term effectiveness.
- Innovative oral medications
- Biological therapeutics
- Long-term disease management
Particular expertise in lupus nephritis treatment strategies and corticosteroid-sparing approaches.
Immune System Disorders
Focuses on the management of complex immune system disorders including investigation of maintenance therapies for sarcoidosis.
- TNF-alpha antagonist therapies
- Remission maintenance strategies
- Immunomodulatory treatments
Specializes in developing treatment protocols for sustained disease control.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.